These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1645050)

  • 21. Prevalence and transmission of human immunodeficiency virus in Japan.
    Kurimura T; Kawatani T; Hattori N; Tsuchie H
    AIDS Res; 1986 Dec; 2 Suppl 1():S163-6. PubMed ID: 3103639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV transfusion suit killed because blood was the patient's.
    AIDS Policy Law; 1999 Jan; 14(1):15. PubMed ID: 11366184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exchange transfusion and pulse steroid therapy in a hemophiliac with inhibitor.
    Chuansumrit A; Isarangkura P; Krutvecho T; Hathirat P; Pintadit P
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():139-43. PubMed ID: 2499649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of an outbreak of hepatitis A in Irish haemophilia A patients.
    Lawlor E; Johnson Z; Thornton L; Temperley I
    Vox Sang; 1994; 67 Suppl 1():18-9; discussion 20. PubMed ID: 8091729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the apparent outbreak of hepatitis A in Belgian hemophiliacs due to a loss of previous passive immunity?
    Peerlinck K; Goubau P; Coppens G; Desmyter J; Vermylen J
    Vox Sang; 1994; 67 Suppl 1():14-6; discussion 17. PubMed ID: 8091728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment type and amount influenced human immunodeficiency virus seroprevalence of patients with congenital bleeding disorders.
    Gjerset GF; Clements MJ; Counts RB; Halvorsen AS; Thompson AR
    Blood; 1991 Sep; 78(6):1623-7. PubMed ID: 1884029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
    McFarland W; Mvere D; Katzenstein D
    AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII product.
    Yee TT; Williams MD; Hill FG; Lee CA; Pasi KJ
    Thromb Haemost; 1997 Sep; 78(3):1027-9. PubMed ID: 9308748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study of HIV-infected haemophilic boys and the prognostic significance of immune and haematological abnormalities.
    Williams MD; al-Rubei K; Hill FG
    Thromb Haemost; 1988 Aug; 60(1):97-101. PubMed ID: 3263713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenesis of peripheral cytopenias in hemophiliac patients].
    Magallón M; Bello JL; Herruzo R; Ortega F; Martín Villar J
    Sangre (Barc); 1989 Oct; 34(5):337-42. PubMed ID: 2515601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biotest position on HIV-1 seroconversions in 1990 in 11 patients, treated with beta-propiolactone/uv virus inactivated PPSB].
    Pustoslemsek P; Kloft M; Kotitschke R
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):344-6. PubMed ID: 8142739
    [No Abstract]   [Full Text] [Related]  

  • 33. Sequence variability of hepatitis A virus and factor VIII associated hepatitis A infections in hemophilia patients in Europe. An update.
    Robertson BH; Friedberg D; Normann A; Graff J; Flehmig B; Shouval D
    Vox Sang; 1994; 67 Suppl 1():39-45; discussion 46. PubMed ID: 8091736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV seroconversion illness - latest HIV assays may still be negative.
    Shields M
    Aust Fam Physician; 2006 Jul; 35(7):523-5. PubMed ID: 16820828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of factor VIII concentrates of very high purity on CD4+ cell count in hemophiliacs infected with HIV].
    Molina Alejandro R; Lorenzo Herrero JI; Haya Guaita S; Querol Fuentes F; Aznar Lucea JA
    Rev Clin Esp; 1996 Jun; 196(6):365-9. PubMed ID: 8767071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening of donor blood for anti-HIV. Experiences from blood donor screening 1986-1988].
    Schmidt KW; Dickmeiss E
    Ugeskr Laeger; 1990 Sep; 152(36):2552-6. PubMed ID: 2402841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV transmission by seronegative blood components: report of 2 probable cases.
    Isarangkura P; Mahaphan W; Chiewsilp P; Chuansumrit A; Hathirat P
    Vox Sang; 1993; 65(2):114-6. PubMed ID: 8212665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemophilia lawsuit.
    AIDS Policy Law; 1999 Apr; 14(6):12. PubMed ID: 11366632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory evidence of active HIV-1 infection in Canadians with hemophilia associated with administration of heat-treated factor VIII.
    Neumann P; O'Shaughnessy M; Remis R; Tsoukas C; Lepine D; Davis M
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):278-81. PubMed ID: 2106024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Human tragedy" was due to delay in achieving national self sufficiency in blood products.
    Dyer C
    BMJ; 2009 Feb; 338():b808. PubMed ID: 19240092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.